Veracyte, Inc.
VCYT
$28.61
-$0.46-1.58%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 26.34M | 33.05M | 24.14M | -9.27M | -54.04M |
| Total Depreciation and Amortization | 22.98M | 23.23M | 23.46M | 23.54M | 24.99M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 62.59M | 47.02M | 48.82M | 67.54M | 96.54M |
| Change in Net Operating Assets | -18.45M | -13.87M | -21.32M | -15.69M | -17.15M |
| Cash from Operations | 93.45M | 89.42M | 75.10M | 66.12M | 50.33M |
| Capital Expenditure | -9.49M | -10.97M | -11.29M | -9.64M | -10.20M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 0.00 | 0.00 | 5.01M | 5.01M | 5.01M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -98.94M | -100.00M | -50.00M | 0.00 | 0.00 |
| Cash from Investing | -108.43M | -110.97M | -56.28M | -4.63M | -5.19M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 20.51M | 19.99M | 19.99M | 18.50M | 8.59M |
| Repurchase of Common Stock | -17.29M | -16.21M | -10.59M | -8.44M | -8.71M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -4.50M | -4.50M | -4.50M | -- | -- |
| Cash from Financing | -1.27M | -716.00K | 4.90M | 10.06M | -120.00K |
| Foreign Exchange rate Adjustments | 392.00K | -242.00K | -424.00K | 274.00K | -49.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -15.85M | -22.51M | 23.30M | 71.83M | 44.97M |